Paragraph 17
Details of any decision in F1a country other than the United Kingdom to refuse to grant an authorisation or registration allowing the medicinal product to be placed on the market, with the reasons for any such decision.
Annotations
Textual amendments
- F1
Words in Sch. 12 para. 17 substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 115(2); 2020 c. 1, Sch. 5 para. 1(1)